accountIRVINE, Calif.--(Business Wire)-- Allergan, Inc. (NYSE:AGN) announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Allergan Announces Victory in Brimonidine Patent Infringement Case
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
